Showing results (611-620 of 786) with videos related to

Sort By:
Pageof 79
In Silico Pharmacology|September 28, 2023
Insilico design of an allosteric modulator targeting the protein-protein interaction site of 3 Phosphoinositide dependent Kinase-1: design, synthesis and biological activityVennila Kailasam Natesan, Selvakumar Balaraman, Elango KuppannaGounder Pitchaimuthu
In Silico Pharmacology|November 16, 2020
In silico predictions on the possible mechanism of action of selected bioactive compounds against breast cancerAliyu Muhammad, Babangida Sanusi Katsayal, Gilead Ebiegberi Forcados, et al.
In Silico Pharmacology|November 13, 2020
Peptide modelling and screening against human ACE2 and spike glycoprotein RBD of SARS-CoV-2Shravan B Rathod, Pravin B Prajapati, Lata B Punjabi, et al.
In Silico Pharmacology|January 5, 2019
Molecular docking and ADME properties of bioactive molecules against human acid-beta-glucosidase enzyme, cause of Gaucher's diseaseVijayakumar Subramaniyan, Sathiya Mathiyalagan, Arulmozhi Praveenkumar, et al.
In Silico Pharmacology|January 5, 2019
Taxifolin as dual inhibitor of Mtb DNA gyrase and isoleucyl-tRNA synthetase: in silico molecular docking, dynamics simulation and in vitro assaysCharles Kozhikkadan Davis, K Nasla, A K Anjana, et al.
In Silico Pharmacology|January 25, 2021
Release characteristics of gliclazide in a matrix systemMehmet Melih Tatlisoz, Esra Demirturk, Cetin Canpolat
In Silico Pharmacology|January 14, 2021
Molecular docking study of lignanamides from Cannabis sativa against P-glycoproteinFarnoosh Kazemi, Isaac Karimi, Namdar Yousofvand
In Silico Pharmacology|February 25, 2021
Characterizing binding intensity and energetic features of histone deacetylase inhibitor pracinostat towards class I HDAC isozymes through futuristic drug designing strategyShabir Ahmad Ganai
In Silico Pharmacology|March 1, 2021
In silico analysis of STX2a-PE15-P4A8 chimeric protein as a novel immunotoxin for cancer therapyMaryam Keshtvarz, Jafar Salimian, Jafar Amani, et al.
In Silico Pharmacology|December 20, 2021
Investigation of phytoconstituents of Enicostemma littorale as potential glucokinase activators through molecular docking for the treatment of type 2 diabetes mellitusAltaf Khan, Aziz Unnisa, Mo Sohel, et al.
Pageof 79